Puma Biotechnology, Inc. (PBYI)
10.22
+0.39
(+3.97%)
USD |
NASDAQ |
Oct 19, 16:00
10.22
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Profit Margin (Quarterly) : 14.49% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.49% |
| March 31, 2026 | -8.37% |
| December 31, 2025 | 17.81% |
| September 30, 2025 | 16.24% |
| June 30, 2025 | 11.17% |
| March 31, 2025 | 6.46% |
| December 31, 2024 | 32.68% |
| September 30, 2024 | 25.23% |
| June 30, 2024 | -9.62% |
| March 31, 2024 | -11.00% |
| December 31, 2023 | 17.00% |
| September 30, 2023 | 10.33% |
| June 30, 2023 | 3.90% |
| March 31, 2023 | 2.65% |
| December 31, 2022 | -8.54% |
| September 30, 2022 | -0.63% |
| June 30, 2022 | 15.74% |
| March 31, 2022 | -7.44% |
| Date | Value |
|---|---|
| December 31, 2021 | 7.62% |
| September 30, 2021 | -96.60% |
| June 30, 2021 | -9.56% |
| March 31, 2021 | 16.84% |
| December 31, 2020 | -28.52% |
| September 30, 2020 | -61.99% |
| June 30, 2020 | 4.81% |
| March 31, 2020 | -33.06% |
| December 31, 2019 | -17.81% |
| September 30, 2019 | -29.96% |
| June 30, 2019 | -69.41% |
| March 31, 2019 | -10.18% |
| December 31, 2018 | -43.18% |
| September 30, 2018 | -22.67% |
| June 30, 2018 | -87.33% |
| March 31, 2018 | -36.60% |
| December 31, 2017 | -296.8% |
| September 30, 2017 | -1.27K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 10.15% |
| Arcutis Biotherapeutics, Inc. | 11.56% |
| Olema Pharmaceuticals, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.64% |
| Return on Assets | 13.35% |
| Return on Invested Capital | 17.65% |
| Gross Profit Margin (Quarterly) | 77.92% |
| Operating Margin (Quarterly) | 13.42% |
| Return on Net Operating Assets | 28.59% |